12 results match your criteria: ""Sf. Ioan cel Nou" Emergency Hospital[Affiliation]"
Healthcare (Basel)
January 2025
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 031593 Bucharest, Romania.
Background: The ongoing military conflict in Ukraine has had a devastating impact on children's health, exposing them to a range of illnesses. The aim of this study was to analyze the most common medical conditions among Ukrainian children since the beginning of the conflict, with a focus on identifying and understanding these problems in a wartime setting.
Method: To assess the health status of affected children, we collected data from 422 pediatric patients who presented to the emergency department.
Medicina (Kaunas)
December 2024
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 050474 Bucharest, Romania.
: The transition from the pediatric to the adult healthcare system is a challenging process involving adolescents, parents, and pediatric and adult specialists. For a successful approach for an organized transition program, we must assess the level of training of adolescents facing transition. : We applied a clinic-based questionnaire measuring perceived self-management skills, adherence to health-related tasks, medication knowledge, and social adjustment to pediatric patients with chronic digestive diseases from North-East Romanian medical units, including a tertiary center and private practice offices.
View Article and Find Full Text PDFLife (Basel)
December 2024
Emergency Hospital' Sf. Ioan Cel Nou', 720224 Suceava, Romania.
Background: SARS-CoV-2 infection is generally associated with less severe forms of disease in children, where most cases only require symptomatic treatment. However, there is a paucity of information regarding the impact and clinical course of COVID-19 in neonate patients. This study aimed to analyze the epidemiological and clinical aspects of COVID-19 in this particular age group who were patients treated in our department.
View Article and Find Full Text PDFJ Clin Med
December 2024
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 050474 Bucharest, Romania.
Interest in the transition of care for cystic fibrosis (CF) patients has grown significantly over time, driven by advancements in treatment that have extended life expectancy. As more CF patients survive into adulthood, the need for structured transition strategies has become a priority for healthcare systems worldwide. Transition programs for CF differ globally, reflecting varying resources and healthcare systems.
View Article and Find Full Text PDFViruses
August 2024
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 031593 Bucharest, Romania.
Background: The COVID-19 pandemic was characterized by mild-to-moderate disease in children and adolescents, with low incidences of severe cases and mortality. Most of the information on drug therapy in COVID-19-positive children was derived from research in adult patients. Remdesivir, an inhibitor of viral RNA polymerase, was shown to be effective in COVID-19 patients with moderate-to-severe disease.
View Article and Find Full Text PDFHealthcare (Basel)
August 2022
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 67A Gheorghe Petrascu Str., 031593 Bucharest, Romania.
Self-medication represents a significant healthcare and health policy issue worldwide, both in developed and underdeveloped countries. Currently, the COVID-19 pandemic is considered a relevant context that could subtly trigger self-medication behavior because of limited access to health care services and the threat of infection with the SARS-CoV-2 virus. While the previous research conducted with quantitative methodologies reported a dramatically increased rate of self-medication around the world, qualitative inquiries on the subjective experience with self-medicine remain scarce in medical and related fields of study.
View Article and Find Full Text PDFChildren (Basel)
September 2022
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 67A Gheorghe Petrascu Str., 031593 Bucharest, Romania.
Introduction: In Romania, studies on the pediatric population regarding infection or bacterial resistance to antibiotics are limited. Eradication treatment of this infection still raises important problems in medical practice. This study aims to compare the effectiveness of three eradication therapies used against infection in the pediatric population.
View Article and Find Full Text PDFJ Clin Med
April 2022
Faculty of Medicine, "Titu Maiorescu" University of Medicine, 67A Gheorghe Petrascu Str., 031593 Bucharest, Romania.
Background and Objectives: The aim of this study was to investigate the association between H. pylori positivity with specific symptoms, risk factors and endoscopic patterns among the pediatric population in northeastern Romania. Materials and Methods: A prospective study was performed in 18 months on 185 children aged 6−18 years with an indication for upper digestive endoscopy.
View Article and Find Full Text PDFBrain Sci
March 2022
Department 5, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Introduction/Aim. The aim of this study was to assess the prevalence of cognitive impairments and their association with sleep patterns in a cohort of patients diagnosed with chronic liver disease (CLD). Material and methods.
View Article and Find Full Text PDFMaedica (Bucur)
September 2021
"Sf. Ioan cel Nou" Emergency Hospital of Suceava, Suceava, Romania.
The theory of vasodilation partially explains the development and progression of liver cirrhosis and is completed by the theory of inflammation. C-reactive protein (CRP) is used as a surrogate marker of inflammation in studies; however, there is not sufficient data that would reflect the role of this protein in cirrhosis yet. The objective of this study was to determine the use of CRP value in the prognosis of patients with cirrhosis.
View Article and Find Full Text PDFCancers (Basel)
January 2021
R&D, Can-Fite BioPharma, 10 Bareket St., P.O.Box 7537, Petah-Tikva 49170, Israel.
Namodenoson, an A3 adenosine-receptor agonist, showed promising results in advanced hepatocellular carcinoma (HCC) and moderate hepatic dysfunction (Child-Pugh B; CPB) in a phase I/II clinical study. This phase II study investigated namodenoson as second-line therapy in such patients. Patients were randomized 2:1 to twice a day (BID) namodenoson (25 mg; = 50) or placebo ( = 28).
View Article and Find Full Text PDF